Viewing Study NCT02851004


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-01-04 @ 3:18 PM
Study NCT ID: NCT02851004
Status: TERMINATED
Last Update Posted: 2021-09-05
First Post: 2016-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Special Combination of BBI608 and Pembrolizumab
Sponsor: Takayuki Yoshino
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module